Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2004 2
2005 1
2006 1
2008 2
2009 1
2014 3
2015 6
2016 4
2017 2
2018 1
2021 1
2022 13
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacokinetics, Safety, and Tolerability of Tenapanor in Healthy Chinese and Caucasian Volunteers: A Randomized, Open-Label, Single-Center, Placebo-Controlled Phase 1 Study.
Yuan G, Chen Y, Li L, Wang X, Wei G, Zeng J, Hui AM, Jiang Y, Zhao H, Diao L, Zhou Y, Xiao Y, Chen M. Yuan G, et al. Among authors: hui am. Int J Clin Pract. 2024 Mar 6;2024:1386980. doi: 10.1155/2024/1386980. eCollection 2024. Int J Clin Pract. 2024. PMID: 38481823 Free PMC article. Clinical Trial.
Model-informed dose selection for an investigational human epidermal growth factor receptor 2 antibody-drug conjugate FS-1502 in patients with human epidermal growth factor receptor 2-expressing advanced malignant solid tumours.
Sun Y, Li C, Wang X, Zheng Y, Wu Z, Hui AM, Diao L. Sun Y, et al. Among authors: hui am. Br J Clin Pharmacol. 2024 Apr;90(4):1115-1129. doi: 10.1111/bcp.15955. Epub 2024 Jan 25. Br J Clin Pharmacol. 2024. PMID: 37926561 Clinical Trial.
Phase 1 dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, and anti-tumor activity of FCN-159 in adults with neurofibromatosis type 1-related unresectable plexiform neurofibromas.
Hu X, Li W, Zeng K, Xu Z, Li C, Kang Z, Li S, Huang X, Han P, Lin H, Hui AM, Tan Y, Diao L, Li B, Wang X, Wu Z, Lin X. Hu X, et al. Among authors: hui am. BMC Med. 2023 Jul 3;21(1):230. doi: 10.1186/s12916-023-02927-2. BMC Med. 2023. PMID: 37400844 Free PMC article. Clinical Trial.
Immunogenicity and safety of BNT162b2 mRNA vaccine in Chinese adults: A phase 2 randomised clinical trial.
Hui AM, Li J, Zhu L, Tang R, Ye H, Lin M, Ge L, Wang X, Peng F, Wu Z, Guo X, Shi Y, Pan H, Zhu J, Song Z, Qiu J, Wang W, Zheng J, Ozhelvaci O, Shpyro S, Bushway M, Derhovanessian E, Kühnle MC, Luxemburger U, Muik A, Shishkova Y, Khondker Z, Hu S, Lagkadinou E, Şahin U, Türeci Ö, Zhu F. Hui AM, et al. Lancet Reg Health West Pac. 2022 Dec;29:100586. doi: 10.1016/j.lanwpc.2022.100586. Epub 2022 Sep 14. Lancet Reg Health West Pac. 2022. PMID: 36120090 Free PMC article.
The Delivery of mRNA Vaccines for Therapeutics.
Nitika, Wei J, Hui AM. Nitika, et al. Among authors: hui am. Life (Basel). 2022 Aug 17;12(8):1254. doi: 10.3390/life12081254. Life (Basel). 2022. PMID: 36013433 Free PMC article. Review.
45 results